BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 18054395)

  • 1. Treatment of Argentine hemorrhagic fever.
    Enria DA; Briggiler AM; Sánchez Z
    Antiviral Res; 2008 Apr; 78(1):132-9. PubMed ID: 18054395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group.
    Maiztegui JI; McKee KT; Barrera Oro JG; Harrison LH; Gibbs PH; Feuillade MR; Enria DA; Briggiler AM; Levis SC; Ambrosio AM; Halsey NA; Peters CJ
    J Infect Dis; 1998 Feb; 177(2):277-83. PubMed ID: 9466512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral treatment of Argentine hemorrhagic fever.
    Enria DA; Maiztegui JI
    Antiviral Res; 1994 Jan; 23(1):23-31. PubMed ID: 8141590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junín Virus and Other Pathogenic New World Arenaviruses.
    Hickerson BT; Westover JB; Wang Z; Lee YM; Gowen BB
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycoprotein precursor gene of Junin virus determines the virulence of the Romero strain and the attenuation of the Candid #1 strain in a representative animal model of Argentine hemorrhagic fever.
    Seregin AV; Yun NE; Miller M; Aronson J; Smith JK; Walker AG; Smith JN; Huang C; Manning JT; de la Torre JC; Paessler S
    J Virol; 2015 Jun; 89(11):5949-56. PubMed ID: 25810546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argentine hemorrhagic fever vaccines.
    Ambrosio A; Saavedra M; Mariani M; Gamboa G; Maiza A
    Hum Vaccin; 2011 Jun; 7(6):694-700. PubMed ID: 21451263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Co-circulation of Junín virus and other mammarenaviruses in a geographical area without confirmed cases of Argentine Hemorrhagic Fever].
    Calderón GE; Provensal MC; Martin ML; Brito Hoyos DM; García JB; Gonzalez-Ittig RE; Levis S
    Medicina (B Aires); 2022; 82(3):344-350. PubMed ID: 35639054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neutralization test for lymphocytic choriomeningitis virus for distinguishing between two arenavirus infections in Argentina].
    Ambrosio AM; Riera L; Saavedra MC; Sottosanti JJ
    Rev Argent Microbiol; 2001; 33(4):235-40. PubMed ID: 11833256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody therapy for Junin virus infection.
    Zeitlin L; Geisbert JB; Deer DJ; Fenton KA; Bohorov O; Bohorova N; Goodman C; Kim D; Hiatt A; Pauly MH; Velasco J; Whaley KJ; Altmann F; Gruber C; Steinkellner H; Honko AN; Kuehne AI; Aman MJ; Sahandi S; Enterlein S; Zhan X; Enria D; Geisbert TW
    Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4458-63. PubMed ID: 27044104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody.
    Zeitlin L; Cross RW; Geisbert JB; Borisevich V; Agans KN; Prasad AN; Enterlein S; Aman MJ; Bornholdt ZA; Brennan MB; Campbell L; Kim D; Mlakar N; Moyer CL; Pauly MH; Shestowsky W; Whaley KJ; Fenton KA; Geisbert TW
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease.
    Emonet SF; Seregin AV; Yun NE; Poussard AL; Walker AG; de la Torre JC; Paessler S
    J Virol; 2011 Feb; 85(4):1473-83. PubMed ID: 21123388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of sensitivity of laboratory animals to a causative agent of argentine hemorrhagic fever].
    Syromiatnikova SI; Pantiukhov VB; Shatokhina IV; Timofeev MA; Sizikova TE; Borisevich SV
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (4):53-7. PubMed ID: 25286529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
    Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
    J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modification of the course of Junin virus infection in guinea pigs by administration of immune sera].
    Laguens RM; Calello MA; Weissenbacher MC; Laguens RP
    Medicina (B Aires); 1985; 45(6):621-6. PubMed ID: 3023791
    [No Abstract]   [Full Text] [Related]  

  • 15. Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever.
    Gowen BB; Juelich TL; Sefing EJ; Brasel T; Smith JK; Zhang L; Tigabu B; Hill TE; Yun T; Pietzsch C; Furuta Y; Freiberg AN
    PLoS Negl Trop Dis; 2013; 7(12):e2614. PubMed ID: 24386500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Oliveros-like Clade C
    Shedroff E; Martin ML; Whitmer SLM; Brignone J; Garcia JB; Sen C; Nazar Y; Fabbri C; Morales-Betoulle M; Mendez J; Montgomery J; Morales MA; Klena JD
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New findings on Junin virus infection in rodents inside and outside the endemic area of hemorrhagic fever in Argentina].
    Mills JN; Calderón GE; Ellis BA; McKee KT; Ksiazek TG; Oro JG; Peters CJ; Childs JE; Maiztegui JI
    Medicina (B Aires); 1991; 51(6):519-23. PubMed ID: 7476104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever.
    Mantlo EK; Maruyama J; Manning JT; Wanninger TG; Huang C; Smith JN; Patterson M; Paessler S; Koma T
    J Virol; 2022 Apr; 96(8):e0020922. PubMed ID: 35343792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preclinical assay of candid #1 vaccine against Argentine Hemorrhagic Fever made in Argentina].
    Ambrosio AM; Riera LM; Saavedra Mdel C; Sottosanti MJ
    Medicina (B Aires); 2005; 65(4):329-32. PubMed ID: 16193711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Junín virus.
    Pan X; Wu Y; Wang W; Zhang L; Xiao G
    Antiviral Res; 2020 Feb; 174():104666. PubMed ID: 31760108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.